The present invention relates to polymorphs and solvates of the hydrochloride salt of 4- [2-[[5-methyl-1 -(2-naphthalenyl)-1 H-pyrazol-3-yl]oxy]ethyl]morpholine (P027), processes for their preparation, and to pharmaceutical compositions comprising them.La presente invención se refiere a polimorfos y solvatos de la sal de clorhidrato de 4-[2-[[5-metil-1-(2-naftalenil)-1H-pirazol-3 -il]oxi]etil]morfolina (P027), a procedimientos para su preparación, y a composiciones farmacéuticas que los comprenden.
